drugset / Trial / NCT00611195

Remifentanil and Laryngeal Reflex Responses in Pediatric Patients With URI

NCT00611195

Phase 4 Completed 62 enrolled Thomas Erb
NaSingle-groupOpen-labelPrevention

Summary

To describe respiratory and laryngeal responses to laryngeal stimulation during propofol anesthesia in children with upper airway infections. To determine whether the co-administration of remifentanil blunts these reflex responses. To test whether the co-administration of remifentanil results in a significant reduction of apnea with laryngospasm in these patients. Hypotheses: I: In children with a URI undergoing anesthesia with propofol, the incidence of apnea and laryngospasm after controlled stimulation is expected to occur 2.5 times more frequently than in children without URI (20 vs. 8%). II: The incidence of apnea and laryngospasm is diminished after administration of remifentanil.

Timeline

Start
2008-01
Primary completion
2012-10
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule 0.05 ug/kg
Background Propofol Small molecule 3 ug/ml